COLL Dividend: Collegium Pharmaceutical Inc Yield Insights

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	757	631	566	463	276	310
Revenue Growth (YoY)	26%	11%	22%	68%	-11%	5%
Cost of Revenue	323	254	240	249	126	130
Gross Profit	433	377	326	214	150	179
Selling, General & Admin	280	210	150	140	116	113
Research & Development	--	0	0	4	9	9
Operating Expenses	276	207	150	144	125	123
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	80	98	75	-28	-3	27
Income Tax Expense	22	29	27	-3	-74	0
Net Income	58	69	48	-25	71	26
Net Income Growth	-34%	44%	-292%	-135%	173%	-218%
Shares Outstanding (Diluted)	39.43	40.42	41.78	33.8	41	35.2
Shares Change (YoY)	-2%	-3%	24%	-18%	16%	5%
EPS (Diluted)	1.48	1.71	1.15	-0.74	1.74	0.76
EPS Growth	-33%	49%	-254.99%	-143%	129%	-212%
Free Cash Flow	289	203	274	-449	101	-279
Free Cash Flow Per Share	7.32	5.02	6.55	-13.28	2.46	-7.92
Gross Margin	57.19%	59.74%	57.59%	46.22%	54.34%	57.74%
Operating Margin	20.6%	26.78%	30.91%	14.9%	9.05%	18.06%
Profit Margin	7.66%	10.93%	8.48%	-5.39%	25.72%	8.38%
Free Cash Flow Margin	38.17%	32.17%	48.4%	-96.97%	36.59%	-90%
EBITDA	382	338	324	203	93	117
EBITDA Margin	50.46%	53.56%	57.24%	43.84%	33.69%	37.74%
D&A For EBITDA	226	169	149	134	68	61
EBIT	156	169	175	69	25	56
EBIT Margin	20.6%	26.78%	30.91%	14.9%	9.05%	18.06%
Effective Tax Rate	27.5%	29.59%	36%	10.71%	2,466.66%	0%

Collegium Pharmaceutical Inc (COLL) Price